New England Research & Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,800
Closed -$402K 163
2024
Q3
$402K Sell
4,800
-587
-11% -$49.2K 0.19% 123
2024
Q2
$370K Sell
5,387
-11,438
-68% -$786K 0.18% 141
2024
Q1
$1.23M Buy
16,825
+11,300
+205% +$827K 0.6% 56
2023
Q4
$448K Buy
+5,525
New +$448K 0.24% 116
2022
Q3
Sell
-12,350
Closed -$763K 172
2022
Q2
$763K Buy
+12,350
New +$763K 0.44% 86
2020
Q3
Sell
-5,410
Closed -$416K 143
2020
Q2
$416K Buy
5,410
+2,250
+71% +$173K 0.3% 102
2020
Q1
$236K Sell
3,160
-17,370
-85% -$1.3M 0.2% 121
2019
Q4
$1.33M Buy
20,530
+11,150
+119% +$725K 0.89% 32
2019
Q3
$595K Sell
9,380
-50
-0.5% -$3.17K 0.43% 85
2019
Q2
$637K Sell
9,430
-475
-5% -$32.1K 0.43% 88
2019
Q1
$644K Sell
9,905
-450
-4% -$29.3K 0.44% 81
2018
Q4
$648K Sell
10,355
-60
-0.6% -$3.76K 0.51% 74
2018
Q3
$804K Hold
10,415
0.52% 71
2018
Q2
$738K Sell
10,415
-13,840
-57% -$981K 0.49% 78
2018
Q1
$1.83M Buy
24,255
+5,550
+30% +$419K 1.23% 15
2017
Q4
$1.34M Buy
18,705
+215
+1% +$15.4K 0.96% 35
2017
Q3
$1.5M Buy
18,490
+2,050
+12% +$166K 1.1% 25
2017
Q2
$1.16M Sell
16,440
-2,325
-12% -$165K 0.86% 37
2017
Q1
$1.28M Sell
18,765
-50
-0.3% -$3.4K 0.98% 27
2016
Q4
$1.35M Buy
18,815
+9,925
+112% +$711K 1.06% 21
2016
Q3
$703K Buy
8,890
+5,625
+172% +$445K 0.59% 57
2016
Q2
$272K Buy
3,265
+175
+6% +$14.6K 0.23% 134
2016
Q1
$284K Sell
3,090
-6,390
-67% -$587K 0.24% 124
2015
Q4
$959K Buy
9,480
+730
+8% +$73.8K 0.83% 34
2015
Q3
$859K Buy
8,750
+900
+11% +$88.4K 0.82% 36
2015
Q2
$919K Sell
7,850
-1,900
-19% -$222K 0.75% 44
2015
Q1
$957K Hold
9,750
0.82% 38
2014
Q4
$919K Sell
9,750
-50
-0.5% -$4.71K 0.79% 37
2014
Q3
$1.04M Sell
9,800
-250
-2% -$26.6K 0.91% 29
2014
Q2
$833K Buy
10,050
+6,050
+151% +$501K 0.75% 52
2014
Q1
$283K Buy
+4,000
New +$283K 0.26% 127